drugset / Trial / NCT00140881

A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)

NCT00140881

Phase 4 Completed 220 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

A 53-week study to determine the effect of montelukast sodium when given to children (with infrequent episodic asthma) at the earliest symptoms of an acute episode of asthma.

Timeline

Start
2000-06-01
Primary completion
2003-02-14
Completion
2003-02-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified

Indications